Nexien BioPharma Inc (NXEN)

[High_Profits]

$NXEN NEXIEN BioPharma & NEW CRX BIO TEAM https://www.crxbio.com/teamcrx/


CRx Bio
MANAGEMENT TEAM
ALEXANDER WASYL.
CEO

https://www.linkedin.com/in/alexwasyl/

Alex is the Managing Director of Elevated Life Sciences and has acquired a decade+ of entrepreneurial and consulting experience in bio-pharmaceutical, biotechnology, food, beverage, nutritional supplements, consumer products, domestic and international pharmaceutical cannabinoid therapeutics, Phyto-medicine therapeutics, and related industries.

Alex possesses an exceptional background in business, marketing, nutritional sciences, biology, biochemistry, and fields. With a true passion for life sciences, Alex is committed to developing strong and strategic companies around innovative products, services, solutions, and other intellectual property that collectively provide people with elevated health and well-being. He is specialized in the formulation of CPG and bio-pharmaceutical technologies, intellectual property development, and concept incubation.

Alex brings forth valuable skills and experience in assembling and leading diverse and highly experienced teams across multiple portfolio companies in varying industry sectors.


JEREMY REEH, M.B., M.B.A.
Chief Scientific Officer

https://www.linkedin.com/in/jeremyreeh/

Jeremy is an accomplished clinical trial and R&D sourcing specialist with 8 years of pharmaceutical industry experience. Jeremy has led the development of R&D partnerships with CROs, specialty labs, academic institutions, and Key Opinion Leaders through executive-level negotiations of licensing, collaboration, confidentiality, service, material transfer, and master agreements. He has supported dozens of development programs across pre-clinical, early/late-stage, and post-marketing across Neuroscience, Metabolic, Oncology, Infectious Disease, and Auto-Immune Diseases.

Jeremy has worked for 4 of the largest 10 Pharmaceutical companies in the world, including Johnson & Johnson, Pfizer, Astra-Zeneca, and Novartis. Jeremy has managed basic and applied research projects at Leidy Laboratories at the University of Pennsylvania as well as the University of California, Irvine Center for Biomembrane Systems.

Jeremy holds a Bachelors in Agricultural Science from Pennsylvania State University, a Masters of Biotechnology (M.B.), from the University of Pennsylvania, and an M.B.A. from the Smeal College of Business at Pennsylvania State University.

LINKEDIN PROFILE
FRANCIS MANGANELLA, M.B.A.
Interim CFO & Head of Business Development

https://www.linkedin.com/in/frank-manganella-8824991/

With over twenty-five years of experience in the financial markets, Francis has a wide ranging set of proficiencies across multiple asset classes, including extensive production skills in fixed income, foreign exchange, derivatives, money markets, credits, commodities and equities. Francis has a history of building, reorganizing and managing international sales and trading teams resulting in an increase in profitability and efficiency, both at commercial institutions as well as within the Broker-Dealer construct.

Prior to entering the Cannabinoid therapeutics industry, Mr. Manganella spent nearly three decades working on Wall Street with leading investment banks and held several managing director positions both regionally and globally.

His previous roles include Head of Fixed Income, Commodities and Currencies Trading, and Sales in a global construct, as well as Head of Equities and Debt Capital Markets, and Head of Emerging Markets Trading for Latin America and Asia.

Francis Manganella was a member of global credit committees and led bank-sponsored credit lending to leading private equity firms. Francis was also the CIO for an international bank’s multi-billion dollar credit portfolio, consisting of corporate and financial sector debt, structured credit and securitized loans. Francis Manganella was also head of business development for several financial services technology firms.


JOSEPH ACETO M.S., JD, PHD.
Resident General & IP Counsel

https://www.linkedin.com/in/joseph-aceto-9452694/


As Counsel with proven legal experience supporting patented technologies in the biotech and medical device industries, Dr. Aceto offers a depth of expertise to CRx Bio. Dr. Aceto maintains a hands-on approach, strong skills in patent prosecution and management, and a focus on minimizing litigation losses and other legal costs to the corporation as his strengths.

Joseph’s background includes strong leadership experience and expertise establishing and maintaining key relationships with scientific and management personnel to provide maximum IP protection worldwide. Furthermore, Joseph is highly successful in forming, managing, and prosecuting all aspects of a global IP portfolio including patent, trademark, and copyright matters, as well as negotiating and facilitating contracts and licensing agreements.